SCHEMBL935837

SCHEMBL935837

CC1(C)OCC(CBr)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936957 1.00
SCHEMBL935836 1.00
SCHEMBL4402227 0.82 CA2 (0.44)
SCHEMBL10314733 0.82 CA2 (0.44)
SCHEMBL1078656 0.82 CA2 (0.44)
SCHEMBL740693 0.80
SCHEMBL4135508 0.80
SCHEMBL7154999 0.80 CA2 (0.50)
SCHEMBL6125258 0.80
SCHEMBL18817541 0.80 CA2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137706-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS INC (US) 2026-05-21 US disclosed
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 WO disclosed
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP disclosed
EP-4724440-A1 METHODS OF TREATING INFLAMMATORY DISEASES Interline Therapeutics, Inc. (US) 2026-04-15 EP disclosed
US-12509462-B2 3-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivatives BioVersys AG (CH) 2025-12-30 US disclosed
US-20250249131-A1 SACCHARIDE-BASED MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-08-07 US disclosed
US-20250206759-A1 FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF FUSED RING COMPOUND CHENGDU HYPERWAY PHARMACEUTICALS CO., LTD. (CN) 2025-06-26 US disclosed
CN-113195493-B 3- (Benzenesulfonyl) - [1,2,3] triazolo [1,5a ] quinazolin-5 (4H) -one derivatives 生物验证系统股份公司 2025-05-02 CN disclosed
EP-4509507-A1 FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF FUSED RING COMPOUND Chengdu Hyperway Pharmaceuticals Co., Ltd. (CN) 2025-02-19 EP disclosed
WO-2024254539-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
US-4851502-A Side chain liquid crystalline condensation polymers exhibiting nonlinear optical response HOECHST CELANESE CORPORATION (US) 1989-07-25 US disclosed
WO-1989000557-A1 AMINOPOLYCARBOXYLIC ACIDS AND DERIVATIVES THEREOF COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) 1989-01-26 WO disclosed
US-4796976-A Side chain liquid crystalline polymeric media exhibiting third order nonlinear optical response HOECHST CELANESE CORP. (US) 1989-01-10 US disclosed
US-4795664-A Side chain liquid crystalline condensation polymers exhibiting nonlinear optical response HOECHST CELANESE CORP. (US) 1989-01-03 US disclosed
US-4762912-A Process for producing polymeric media exhibiting third order nonlinear optical response HOECHST CELANESE CORPORATION (US) 1988-08-09 US disclosed
EP-0262680-A2 Side chain liquid crystalline polymeric media exhibiting third order nonlinear optical response HOECHST CELANESE CORPORATION (US) 1988-04-06 EP disclosed
US-4648895-A ANTIDOTES CIBA-GEIGY CORPORATION (US) 1987-03-10 US disclosed
EP-0177414-A1 Jodized triaminobenzene compounds, process for their preparation and their use in contrast products GUERBET S.A. (FR) 1986-04-09 EP disclosed
EP-0092517-B1 OXIME ETHERS, PROCESS FOR THEIR PREPARATION, AGENTS CONTAINING THESE COMPOUNDS AND THEIR USE CIBA-GEIGY AG (CH) 1986-03-12 EP disclosed
EP-0092517-A1 Oxime ethers, process for their preparation, agents containing these compounds and their use CIBA-GEIGY AG (CH) 1983-10-26 EP disclosed